Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)
Barp A, Laforêt P, Bello L, et al.
Journal of neurology, 2019
Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III
Tobaly D, Laforêt P, Perry A, et al.
Muscle & Nerve, 2019
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
Pane M, Coratti G, Brogna C, et al.
PLoS ONE, 2018, 13, 6, 8 p.
The first French case of MATR3-related distal myopathy: Clinical, radiological and histopathological characterization.
Barp A, Malfatti E, Metay C, et al.
Revue neurologique, 2018, 4 p.
Muscle MRI and functional outcome measures in Becker muscular dystrophy.
Barp A, Bello L, Caumo L, et al.
Scientific Reports, 2017, 7, 1, 13 p.
Association Study of Exon Variants in the NF-kappaB and TGFbeta Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.
Bello L, Flanigan KM, Weiss RB, et al.
American journal of human genetics, 2016, Epub, 9 p.
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies
Bello L, Campadello P, Barp A, et al.
Scientific Reports, 2016, 6, 10 p.
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
Barp A, Bello L, Politano L, et al.
PLoS ONE, 2015, e0141240, 14 p.
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test.
Pane M, Fanelli L, Mazzone ES, et al.
Neuromuscular disorders : NMD, 2015, 25, 10, p. 749-53
The 6 minute walk test and performance of upper limb in ambulant Duchenne Muscular Dystrophy boys
Pane M, Mazzone ES, Sivo S, et al.
PLoS Currents, 2014, 1, 6 p.
Long term natural history data in ambulant boys with Duchenne Muscular Dystrophy : 36 month changes
Pane M, Mazzone ES, Sivo S, et al.
PLoS ONE, 2014, 9, 10, p.1-6
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.
Pane M, Mazzone ES, Fanelli L, et al.
Neuromuscular disorders : NMD, 2014, 24, 3, p. 201-206
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
Bello L, Piva L, Barp A, et al.
Neurology, 2012, 79, 2, p. 159-162
